Cargando…

BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

BACKGROUND: BRCC3 has been found to be aberrantly expressed in breast tumors and involved in DNA damage response. The contribution of BRCC3 to nasopharyngeal carcinoma prognosis and radiosensitivity is still unclear. METHODS: Immunohistochemical analysis of BRCC3 was carried out in 100 nasopharyngea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Ziwei, Xu, Bingqing, Qu, Chen, Tao, Yalan, Chen, Chen, Hua, Wenfeng, Feng, Guokai, Chang, Hui, Liu, Zhigang, Li, Guo, Jiang, Changbin, Yi, Wei, Zeng, Musheng, Xia, Yunfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511524/ https://www.ncbi.nlm.nih.gov/pubmed/26024915 http://dx.doi.org/10.1186/s13014-015-0427-3

Ejemplares similares

RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma
por: Qu, Chen, et al.
Publicado: (2017)

CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis
por: Tu, Ziwei, et al.
Publicado: (2016)

Structural Basis of BRCC36 Function in DNA Repair and Immune Regulation
por: Rabl, Julius, et al.
Publicado: (2019)

Identification of BRCC3 and BRCA1 as Regulators of TAZ Stability and Activity
por: Sberna, Silvia, et al.
Publicado: (2023)

Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma
por: Yu, Bin-Bin, et al.
Publicado: (2018)

Knockdown of BRCC3 exerts an anti-tumor effect on cervical cancer in vitro
por: Zhang, Feifang, et al.
Publicado: (2018)

Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
por: Rao, Zebing, et al.
Publicado: (2019)

Higher -Order Assembly of BRCC36–KIAA0157 Is Required for DUB Activity and Biological Function
por: Zeqiraj, Elton, et al.
Publicado: (2015)

BRCC36A is epistatic to BRCA1 in DNA crosslink repair and homologous recombination in Arabidopsis thaliana
por: Block-Schmidt, Astrid S., et al.
Publicado: (2011)

BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway
por: Li, X, et al.
Publicado: (2013)

BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage
por: Biswas, Kajal, et al.
Publicado: (2018)

Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy
por: Le, Ziyu, et al.
Publicado: (2017)

Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy
por: Lin, Jiabao, et al.
Publicado: (2017)

Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study
por: Li, Xiaohui, et al.
Publicado: (2016)

SHMT2 and the BRCC36/BRISC deubiquitinase regulate HIV-1 Tat K63-ubiquitylation and destruction by autophagy
por: Xu, Muyu, et al.
Publicado: (2018)

Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
por: Meyer, Tatjana, et al.
Publicado: (2019)

UCA1 executes an oncogenic role in pancreatic cancer by regulating miR-582-5p/BRCC3
por: Hu, Xiaole, et al.
Publicado: (2023)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma
por: Li, Siwei, et al.
Publicado: (2016)

Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma
por: Liu, Yijun, et al.
Publicado: (2020)

BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-κB Signaling Pathway Through Targeting TRAF2
por: Tao, Huangheng, et al.
Publicado: (2021)

miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis
por: Scalavino, Viviana, et al.
Publicado: (2023)

Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
por: Li, Qian, et al.
Publicado: (2021)

Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
por: Liao, Lie-Qiang, et al.
Publicado: (2016)

Radiation-induced functional connectivity alterations in nasopharyngeal carcinoma patients with radiotherapy
por: Ma, Qiongmin, et al.
Publicado: (2016)

Radiation-Induced Temporal Lobe Injury for Nasopharyngeal Carcinoma: A Comparison of Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy
por: Zhou, Guan-Qun, et al.
Publicado: (2013)

Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy
por: Zong-wen, Sun, et al.
Publicado: (2018)

Prognostic Factors and Survival in Patients with Radiation-Related Second Malignant Neoplasms Following Radiotherapy for Nasopharyngeal Carcinoma
por: Xi, Mian, et al.
Publicado: (2013)

Case Report: Successful Cerebral Revascularization and Cardiac Transplant in a 16-Year-Old Male With Syndromic BRCC3-Related Moyamoya Angiopathy
por: Pyra, Pierrick, et al.
Publicado: (2021)

Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2017)

In Vivo Imaging Markers for Prediction of Radiotherapy Response in Patients with Nasopharyngeal Carcinoma: RESOLVE DWI versus DKI
por: Huang, Wei-Yuan, et al.
Publicado: (2018)

A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy
por: Bai, Penggang, et al.
Publicado: (2020)

Intensity-modulated radiotherapy controls nasopharyngeal carcinoma distant metastasis and improves survival of patients
por: Chen, Xiaoqian, et al.
Publicado: (2016)

Effect of relevant factors on radiation‐induced nasopharyngeal ulcer in patients with primary nasopharyngeal carcinoma treated with intensity‐modulated radiation therapy
por: Fei, Zhaodong, et al.
Publicado: (2020)

Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy
por: Zhai, Ruiping, et al.
Publicado: (2022)

CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma
por: Chen, Ruiwan, et al.
Publicado: (2015)

Prediction of Changes in Tumor Regression during Radiotherapy for Nasopharyngeal Carcinoma by Using the Computed Tomography-Based Radiomics
por: Yang, Yu, et al.
Publicado: (2022)

Prognostic factors for survival of patients with nasopharyngeal carcinoma following conventional fractionation radiotherapy
por: KONG, FEI, et al.
Publicado: (2013)

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
por: Chen, Zhuo, et al.
Publicado: (2015)

PKCα is a Potentially Useful Marker for Planning Individualized Radiotherapy for Nasopharyngeal Carcinoma
por: Zhang, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5bqvfn786477rsqqs9f9fffq4e